Description

Lenvatinib is a medication used primarily for the treatment of certain types of cancer, including thyroid cancer and hepatocellular carcinoma. It works as a kinase inhibitor, targeting multiple receptor tyrosine kinases involved in tumor growth and angiogenesis.

Interpreter Notes

Interpreters should be aware that 'Lenvatinib' may be referred to in various ways, including its brand name in some contexts. It is important to maintain a formal register and use the canonical term in clinical discussions to avoid confusion with other medications.

Example Sentences

EN: The oncologist recommended Lenvatinib as a treatment option for the patient's advanced thyroid cancer.

ES: El oncólogo recomendó Lenvatinib como una opción de tratamiento para el cáncer de tiroides avanzado del paciente.

Common Interpreter Mistakes

Confusing Lenvatinib with other similar-sounding medications; mispronouncing Lenvatinib due to unfamiliarity; using informal language when discussing the medication.